ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FGEN FibroGen Inc

1.11
-0.08 (-6.72%)
Jun 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -6.72% 1.11 18:45:26
Open Price Low Price High Price Close Price Previous Close
1.15 1.10 1.18 1.10 1.19
more quote information »

Recent News

Date Time Source Heading
6/07/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:12EDGAR2Form 8-K - Current report
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202415:05GLOBEFibroGen Announces Clinical Trial Supply Agreement with..
6/03/202415:02GLOBEFibroGen Announces FDA Clearance of Investigational New Drug..
6/03/202406:00GLOBEFibroGen to Present at Goldman Sachs 45th Annual Global..
5/23/202416:05GLOBEFibroGen Announces Presentation of Positive Interim Data..
5/07/202410:55APSTraders Rush To Buy Biotech Following Q1 Earnings Beat
5/07/202406:00GLOBEFibroGen to Participate in Upcoming Investor Conferences
5/06/202415:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202415:05EDGAR2Form 8-K - Current report
5/06/202415:02GLOBEFibroGen Reports First Quarter 2024 Financial Results
4/29/202406:00GLOBEFibroGen to Report First Quarter 2024 Financial Results
4/24/202415:02GLOBEFibroGen Announces Clinical Data from Dose Escalation Phase..
4/02/202416:46GLOBEFibroGen Announces Topline Results from Phase 1 Monotherapy..
3/26/202406:00GLOBEFibroGen to Present at 23rd Annual Needham Virtual..
3/11/202406:00GLOBEFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
3/08/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202415:08EDGAR2Form 8-K - Current report
2/26/202415:06GLOBEFibroGen Reports Fourth Quarter and Full Year 2023 Financial..
2/26/202415:05GLOBEFibroGen Regains All Rights to Roxadustat from AstraZeneca..
2/23/202419:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202419:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202406:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2023..
2/14/202414:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/05/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202406:00GLOBEFibroGen To Host Part I of Virtual KOL Investor Event Series..
1/25/202406:00GLOBEFibroGen Announces Completion of the Pamrevlumab Arm in..
12/26/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202316:02GLOBEFibroGen Presents Data from Phase 3 MATTERHORN Trial of..
11/06/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202315:05EDGAR2Form 8-K - Current report
11/06/202315:01GLOBEFibroGen Reports Third Quarter 2023 Financial Results
11/03/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/27/202315:30EDGAR2Form 8-K - Current report
10/23/202306:00GLOBEFibroGen to Report Third Quarter 2023 Financial Results
9/25/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..